Newsflash: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Analysts Have Been Trimming Their Revenue Forecasts

Today is shaping up negative for Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) shareholders, with the analysts delivering…